Found: 4
Select item for more details and to access through your institution.
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors.
- Published in:
- BMC Cancer, 2016, v. 18, p. 1, doi. 10.1186/s12885-016-2933-6
- By:
- Publication type:
- Article
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 ( MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 4, p. 676, doi. 10.1002/cam4.635
- By:
- Publication type:
- Article
A soluble chimeric inhibitor of C3 and C5 convertases, complement activation blocker-2, prolongs graft survival in pig-to-rhesus monkey heart transplantation.
- Published in:
- Xenotransplantation, 2002, v. 9, n. 2, p. 125, doi. 10.1034/j.1399-3089.2002.1o042.x
- By:
- Publication type:
- Article